Skip to main content

News & Articles

UTHealth Research

March 23, 2022
Written By: Jeannette Sanchez | Updated: March 23, 2022
The Cancer Prevention and Research Institute of Texas (CPRIT) awarded over $6 million to researchers with UTHealth Houston to aid in cancer prevention research. These awards will expand liver cancer prevention to persons experiencing homelessness, facilitate communication about the HPV vaccine, and find therapeutics that can help destroy gastrointestinal cancer cells.
February 15, 2022
Written By: Caitie Barkley | Updated: February 15, 2022
After examining Kristi Taylor in November 2020, J. William Lindsey, MD, a neurologist with UTHealth Houston, determined she was an ideal candidate for a clinical trial that is testing the efficacy and safety of fenebrutinib – a medication that inhibits the activity of certain malignant white blood cells – on the progression of disability in adult participants with primary progressive multiple sclerosis.
January 13, 2022
Written By: Roman Petrowski | Updated: January 13, 2022

An innovative academic drug discovery program at The University of Texas Health Science Center at Houston (UTHealth Houston) has earned Zhiqiang An, PhD, professor and director of the Texas Therapeutics Institute of the Brown Foundation Institute of Molecular Medicine at McGovern Medical School, a fellowship with the National Academy of Inventors (NAI).